Clinical Trials Logo

Clinical Trial Summary

This study is to look at things that may affect whether or not people who are HIV-infected get into medical care and stay in medical care. some of the things that will be examined include how drug use, HIV disease severity, mental health, housing, trust, feelings of discrimination, social support, relationship with provider, and patient's race and provider's race are linked with whether or not people get health care. People who are enrolled in the study will be interviewed once, and their medical records will be examined.


Clinical Trial Description

The purpose of this study is to understand the determinants of entry and engagement in HIV primary care services for Blacks and Hispanics living in single room occupancy (SRO) hotels in Bronx and Manhattan, NY. More specifically, the goal is to examine baseline cultural characteristics of the patient, health-related characteristics of the patient, the patient-provider relationship, and the impact of community outreach on engagement in health care. The objectives are to: examine the association between trust, relationship with provider, social support, and health beliefs with engagement in HIV primary care services; examine the association between health-related characteristics and engagement in HIV primary care services; examine the association of perceived cultural concordance between provider and patient with engagement in HIV primary care services; and, explore the relationship between community outreach and entry into HIV primary care services.

We will be recruiting a convenience sample of 500 Black or Hispanic HIV-infected adults living in 14 SRO hotels (transitional emergency housing) in the Bronx and Manhattan, NY. We will be conducting interviews through auditory computer-assisted self-interviewing (A-CASI) technology, using standardized research instruments administered in English or Spanish. We will also be reviewing medical charts and records from Citiwide and Montefiore appointment databases.

Understanding barriers to engagement in HIV primary care will lead to development of culturally relevant interventions to assist Black and Hispanic persons in entering and engaging in HIV treatment. Implementation of these interventions will ultimately help reduce disparities in HIV-related healthcare, as well as reduce HIV morbidity and mortality in Black and Hispanic populations. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00300170
Study type Observational
Source Montefiore Medical Center
Contact
Status Completed
Phase
Start date October 2004
Completion date June 2005

See also
  Status Clinical Trial Phase
Completed NCT05454514 - Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS N/A
Completed NCT03760458 - The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age Phase 1/Phase 2
Completed NCT03141918 - Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS N/A
Completed NCT03067285 - A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study Phase 4
Recruiting NCT04579146 - Coronary Artery Disease (CAD) in Patients HIV-infected
Completed NCT06212531 - Papuan Indigenous Model of Male Circumcision N/A
Active, not recruiting NCT03256422 - Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients Phase 3
Completed NCT03256435 - Retention in PrEP Care for African American MSM in Mississippi N/A
Completed NCT00517803 - Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies N/A
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Completed NCT04165200 - Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV N/A
Recruiting NCT03854630 - Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection Phase 4
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT02234882 - Study on Pharmacokinetics Phase 1
Completed NCT01618305 - Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission Phase 4
Recruiting NCT05043129 - Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
Not yet recruiting NCT05536466 - The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine N/A
Recruiting NCT04985760 - Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy Phase 1
Completed NCT05916989 - Stimulant Use and Methylation in HIV
Terminated NCT02116660 - Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) Phase 2